Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$548.35 - $738.84 $2.43 Million - $3.27 Million
-4,427 Closed
0 $0
Q3 2021

Nov 17, 2021

BUY
$574.03 - $680.96 $2.43 Million - $2.88 Million
4,228 Added 2124.62%
4,427 $116,000
Q2 2021

Aug 11, 2021

BUY
$472.8 - $558.54 $94,087 - $111,149
199 New
199 $112,000
Q4 2020

Feb 17, 2021

SELL
$478.3 - $607.98 $175,536 - $223,128
-367 Closed
0 $0
Q2 2020

Aug 17, 2020

SELL
$493.32 - $643.92 $39,465 - $51,513
-80 Reduced 17.9%
367 $229,000
Q1 2020

May 14, 2020

SELL
$336.18 - $494.43 $50,090 - $73,670
-149 Reduced 25.0%
447 $218,000
Q4 2019

Feb 27, 2020

BUY
$274.13 - $376.51 $163,381 - $224,399
596 New
596 $223,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Wealth Quarterback LLC Portfolio

Follow Wealth Quarterback LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Quarterback LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Quarterback LLC with notifications on news.